En Bloc Resection with Major Blood Vessel Reconstruction for Locally Invasive Retroperitoneal Paragangliomas: A 15-Year Experience with Literature Review
- PMID: 27896404
- DOI: 10.1007/s00268-016-3846-x
En Bloc Resection with Major Blood Vessel Reconstruction for Locally Invasive Retroperitoneal Paragangliomas: A 15-Year Experience with Literature Review
Abstract
Background: Retroperitoneal paragangliomas (PGs) are a rare subgroup of neuroendocrine tumors that are commonly located alongside the abdominal aorta. Complete tumor resection is thought to be restricted in patients with major blood vessel involvement. However, no study has specifically focused on aggressive surgical treatment in such patients. We evaluated the value of en bloc resection with major blood vessel reconstruction for locally invasive retroperitoneal PGs.
Methods: Twenty-nine patients with retroperitoneal PGs with major blood vessel involvement were included in this retrospective study. Survival was compared between patients who underwent en bloc resection with major blood vessel reconstruction and those who underwent medical treatment. Prognostic predictors were analyzed in patients who underwent en bloc resection with major blood vessel reconstruction.
Results: All 11 patients who underwent medical treatment obtained a pathological diagnosis by computed tomography-guided percutaneous needle biopsy. All 18 patients who underwent en bloc resection with major blood vessel reconstruction achieved complete tumor resection. Overall survival was higher in patients who underwent complete tumor resection than in those who underwent medical treatment (p < 0.05). No perioperative mortality occurred in patients who underwent complete tumor resection. Patients with no metastasis, no organ invasion, R0 resection, a Ki-67 index of ≤3%, and a tumor diameter of ≤11.7 cm showed better tumor-free survival (p < 0.05).
Conclusions: En bloc resection with major blood vessel reconstruction can be successfully performed and provide satisfactory outcomes for patients with locally invasive retroperitoneal PGs. This technique may become a standard surgical strategy for properly selected patients.
Similar articles
-
Clinical results of surgery for retroperitoneal sarcoma with major blood vessel involvement.J Vasc Surg. 2006 Jul;44(1):46-55. doi: 10.1016/j.jvs.2006.03.001. J Vasc Surg. 2006. PMID: 16828425 Review.
-
En bloc resection for intra-abdominal/retroperitoneal desmoid-type fibromatosis with adjacent organ involvement: A case series and literature review.Biosci Trends. 2018;12(6):620-626. doi: 10.5582/bst.2018.01285. Biosci Trends. 2018. PMID: 30674762 Review.
-
Inferior vena cava resection and reconstruction for retroperitoneal tumor excision.J Vasc Surg. 2012 May;55(5):1386-93; discussion 1393. doi: 10.1016/j.jvs.2011.11.054. Epub 2012 Mar 2. J Vasc Surg. 2012. PMID: 22386140
-
Outcomes of arterial bypass preceding resection of retroperitoneal masses involving major vessels.J Surg Res. 2018 Oct;230:34-39. doi: 10.1016/j.jss.2018.04.039. Epub 2018 May 15. J Surg Res. 2018. PMID: 30100037
-
Anterior Approach to En Bloc Resection in Left-Sided Retroperitoneal Sarcoma with Adjacent Organ Involvement: A Study of 25 Patients in a Single Center.Med Sci Monit. 2018 Feb 16;24:961-969. doi: 10.12659/msm.908559. Med Sci Monit. 2018. PMID: 29449525 Free PMC article.
Cited by
-
Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.BMC Surg. 2020 Nov 7;20(1):272. doi: 10.1186/s12893-020-00933-2. BMC Surg. 2020. PMID: 33160340 Free PMC article.
-
Patterns of Metastatic Recurrence of Genetically Confirmed Myxoid Liposarcoma.Ann Surg Oncol. 2023 Jul;30(7):4489-4497. doi: 10.1245/s10434-023-13312-x. Epub 2023 Mar 12. Ann Surg Oncol. 2023. PMID: 36907960 Free PMC article. Review.
-
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.Nat Rev Endocrinol. 2024 Mar;20(3):168-184. doi: 10.1038/s41574-023-00926-0. Epub 2023 Dec 14. Nat Rev Endocrinol. 2024. PMID: 38097671 Review.
-
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.Lancet Diabetes Endocrinol. 2023 May;11(5):345-361. doi: 10.1016/S2213-8587(23)00038-4. Epub 2023 Mar 31. Lancet Diabetes Endocrinol. 2023. PMID: 37011647 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials